IDEXX Laboratories (IDXX)
Provides veterinary diagnostics, reference laboratories, and practice software for connected clinical workflows.
$517.95
vs last close−3.55 (−0.68%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 916 | 902 | 964 | 1,004 | 976 | 954 | 998 | 1,109 | 1,105 | 1,091 | 1,141 | 1,217 |
| Cost of revenue | 368 | 375 | 371 | 383 | 380 | 384 | 375 | 415 | 422 | 432 | 418 | 437 |
| Gross profit | 548 | 526 | 593 | 621 | 596 | 571 | 623 | 695 | 683 | 658 | 723 | 779 |
| 273 | 281 | 294 | 355 | 292 | 309 | 307 | 322 | 329 | 343 | 360 | 354 | |
| Research & development | 48 | 52 | 53 | 55 | 54 | 58 | 59 | 62 | 63 | 67 | 66 | 65 |
| 225 | 229 | 241 | 300 | 238 | 251 | 248 | 260 | 265 | 276 | 294 | 288 | |
| Selling & marketing | 136 | 142 | 149 | 143 | 146 | 150 | 156 | 161 | 159 | 167 | 175 | 171 |
| General & administrative | 89 | 87 | 92 | 157 | 92 | 101 | 92 | 99 | 106 | 109 | 119 | 117 |
| Operating income | 275 | 245 | 299 | 264 | 304 | 262 | 317 | 373 | 355 | 316 | 363 | 426 |
| −7 | −6 | −3 | −5 | −5 | −5 | −6 | −11 | −10 | −9 | −7 | −8 | |
| Interest income | 1 | 4 | 4 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest expense | 9 | 9 | 8 | 8 | 8 | 7 | 8 | 11 | 11 | 11 | 8 | 10 |
| Other non-operating income | −1 | −4 | −4 | −3 | −3 | −2 | −1 | −1 | −1 | −2 | −1 | −2 |
| Income before tax | 268 | 240 | 295 | 259 | 299 | 256 | 310 | 362 | 345 | 307 | 355 | 417 |
| Income tax expense | 56 | 45 | 60 | 56 | 66 | 40 | 67 | 68 | 70 | 59 | 77 | 79 |
| Net income from continuing operations | 212 | 195 | 236 | 203 | 233 | 216 | 243 | 294 | 275 | 248 | 278 | 338 |
| Net income | 212 | 195 | 236 | 203 | 233 | 216 | 243 | 294 | 275 | 248 | 278 | 338 |
| EPS, basic | $2.55 | $2.34 | $2.84 | $2.46 | $2.83 | $2.63 | $2.98 | $3.66 | $3.43 | $3.10 | $3.48 | $4.23 |
| EPS, diluted | $2.53 | $2.32 | $2.81 | $2.44 | $2.80 | $2.62 | $2.96 | $3.63 | $3.40 | $3.08 | $3.45 | $4.19 |
| Weighted average shares, basic | 83 | 83 | 83 | 83 | 82 | 82 | 81 | 80 | 80 | 80 | 80 | 80 |
| Weighted average shares, diluted | 84 | 84 | 84 | 83 | 83 | 83 | 82 | 81 | 81 | 81 | 81 | 81 |
| EBITDA | 306 | 279 | 335 | 301 | 342 | 299 | 352 | 409 | 392 | 356 | 401 | 468 |
| Depreciation & amortization | 29 | 30 | 30 | 32 | 34 | 34 | 34 | 36 | 37 | 39 | 38 | 41 |
| EBIT | 277 | 249 | 303 | 267 | 307 | 265 | 318 | 374 | 355 | 317 | 363 | 427 |